MYL

Mylan Inc. News Headlines

$48.68
*  
0.08
0.16%
Get MYL Alerts
*Delayed - data as of Sep. 2, 2014  -  Find a broker to begin trading MYL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Actavis Files ANDA for Endo Product - Analyst Blog
3/5/2013 5:40:01 PM - Zacks.com

Dr. Reddy's Launches Generic Zometa - Analyst Blog
3/5/2013 4:40:01 PM - Zacks.com

FDA Approves Actavis Generic - Analyst Blog
3/1/2013 1:10:01 PM - Zacks.com

Impax Beats on Both Counts - Analyst Blog
3/1/2013 1:00:01 PM - Zacks.com

Market Close Report: NASDAQ Composite index closes at 3,160.19 down -2.07 points
2/28/2013 5:45:13 PM - NASDAQ.com News

Market Wrap for Thursday, February 28: Stocks close Little Changed
2/28/2013 5:30:36 PM - Benzinga

Mid-Morning Market Update: Markets Rise, Groupon Issues Downbeat Forecast
2/28/2013 11:23:38 AM - Benzinga

Mylan Beats by a Penny, Guides Up - Analyst Blog
2/28/2013 9:40:01 AM - Zacks.com

After-Hours Earnings Report for February 27, 2013 : CLR, LTD, MYL, PLL, MWE, WLL, WES, CBI, JCP, ITC, GRPN, IOC
2/27/2013 3:00:04 PM - NASDAQ.com News

Generic Segment at Mylan Boosted - Analyst Blog
2/26/2013 5:27:43 PM - Zacks.com

The Week Ahead: Earnings from JC Penney, Groupon, Salesforce
2/22/2013 6:16:27 PM - Benzinga

FDA Approves Teva's Generic - Analyst Blog
2/21/2013 1:30:01 PM - Zacks.com

Billionaire John Paulson's Top Stock Picks
2/21/2013 8:21:00 AM - Seeking Alpha

Raptor Trades Weak Ahead Of Flagship Drug's FDA Decision
2/20/2013 1:26:00 PM - Seeking Alpha

Actavis Beats on Earnings - Analyst Blog
2/19/2013 4:39:01 PM - Zacks.com

Dr. Reddy's Misses on Both Counts - Analyst Blog
2/15/2013 12:00:01 PM - Zacks.com

Mylan Extends Biocon Collaboration - Analyst Blog
2/14/2013 5:30:01 PM - Zacks.com

Teva Enrolls First Patient in Study - Analyst Blog
2/12/2013 6:10:01 PM - Zacks.com

Perrigo in Expansion Mode - Analyst Blog
2/12/2013 5:15:01 PM - Zacks.com

Why Raptor Could Run Up To Its PDUFA
2/11/2013 5:49:00 PM - Seeking Alpha

Lannett Beats, Ups Guidance - Analyst Blog
2/11/2013 3:24:01 PM - Zacks.com

Supernus' Update on Oxtellar - Analyst Blog
2/8/2013 5:15:01 PM - Zacks.com

FDA Nod for Warner Chilcott Drug - Analyst Blog
2/8/2013 3:00:01 PM - Zacks.com

Teva Misses, Hikes Dividend - Analyst Blog
2/8/2013 10:40:01 AM - Zacks.com

Why You Should Hold On To Mylan
2/7/2013 2:38:00 AM - Seeking Alpha